Last $4.31 USD
Change Today +0.12 / 2.86%
Volume 1.0M
IDIX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David N. Standring Ph.D.

Chief Scientific Officer and Executive Vice President, Idenix Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

61$1,401,683
As of Fiscal Year 2012

Background*

Dr. David N. Standring, Ph.D., has been Chief Scientific Officer and Executive Vice President of Idenix Pharmaceuticals Inc. since February 2011. Dr. Standring served as Executive Vice President, Biology of Idenix Pharmaceuticals Inc. from December 2007 to February 2011. Dr. Standring served as Vice President of Biology of Idenix Pharmaceuticals Inc. from March 2002 to March 2006 and as its Senior Vice President of Biology from March 2006 to December 2007. He served ...

Read Full Background

Corporate Headquarters*

60 Hampshire Street
Cambridge, Massachusetts 02139

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Harvard University
BA
St John's College, Oxford University

Other Affiliations*

Annual Compensation*

Salary$324,038
Total Annual Compensation$324,038

Stock Options*

All Other Compensation$8,120
Exercisable Options354,063
Exercisable Options Value$244,528
Unexercisable Options175,937
Unexercisable Options Value$136,922
Total Value of Options$381,450
Total Number of Options530,000

Total Compensation*

Total Annual Cash Compensation$425,158
Total Short Term Compensation$324,038
Other Long Term Compensation$8,120
Total Calculated Compensation$1,401,683
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDIX:US $4.31 USD +0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.6M
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
1.9M GBP
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDENIX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.